Future research will involve new methods for the synthesis of the product in step three and more effective ways to synthesize N-phenyloxyphthalimide, from step two, more purely. This research will also include the synthesis of the products of step three and four, that was not able to be conducted. Once the drug, O-(4-methyl)-phenyl-N-(9’acridnyl)-hydroxylamine, is synthesized, further research will be done to find new, more effective ways of synthesizing it. In addition, more research would have to be done to find the effect of the drug on DNA, to see whether the drug is truly effective in stopping DNA replication. The purity of the compound in each step would also have to be tested in order to make the drug in high yields. Research would also have to be conducted in vivo and vitro to see the effects of the drug and to determine whether the drug is truly less susceptible to hydrolysis and can last in vitro and vivo for a longer period of time than other chemotherapy drugs. Once the drug is tested in both vitro and vivo it will move on to see the effects in mice and other animals. Then the drug would have to be tested in humans and the side effects would be evaluated. Although O-(4-methyl)-phenyl-N-(9’acridnyl)-hydroxylamine was not synthesized completely in this six week period, research proves that the drug could be synthesized with specific and inert conditions.